Mary PatGallagherMD

Pediatric Endocrinology • New York, NY

Pediatric Diabetes Endocrinology

Assistant Professor, Pediatrics, Hassenfeld Children's Hospital at NYU Langone

Join to view full profile

Dr. Gallagher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gallagher's full profile

Already have an account?

Office
1150 Saint Nicholas Ave
New York, NY 10032
Phone+1 212-851-5494

Fax+1 212-851-5493

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Endocrinology, 1999 - 2002
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1995 - 1999
Rutgers New Jersey Medical SchoolClass of 1995

Certifications & Licensure

NY State Medical License 1998 - 2025
CT State Medical License 2005 - 2006
NJ State Medical License 2002 - 2005
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

New York Magazine: Top Doctors 2013-2022
Super Doctor SuperDoctors.com, 2009-2010, 2012-2022
Castle Connolly Top Doctors: New York Metro Area 2009-2022
Castle Connolly America's Top Doctors 2014-2019
Join now to see all

Clinical Trials

TrialNet Pathway to Prevention of T1D Start of enrollment: 2004 Feb 01
Recruiting
New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial Start of enrollment: 2004 May 01
Completed
Phase 2
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials Start of enrollment: 2004 Nov 01
Completed
Not Applicable
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus Start of enrollment: 2007 Feb 01
Completed
Phase 3
Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus Start of enrollment: 2008 Feb 01
Completed
Phase 2
Study of Antithymocyte Globulin for Treatment of New-onset T1DM Start of enrollment: 2007 Aug 01
Terminated
Phase 2
Proleukin and Rapamune in Type 1 Diabetes Start of enrollment: 2007 Aug 01
Completed
Phase 1
Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects Start of enrollment: 2009 Feb 01
Completed
Phase 2
Treatment With hOKT3gamma1(Ala-Ala) in T1DM Start of enrollment: 2002 May 01
Terminated
Phase 2
Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes Start of enrollment: 2010 Oct 01
Completed
Phase 2
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk" Start of enrollment: 2010 Aug 01
Completed
Phase 2
A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II Start of enrollment: 2010 Oct 01
Withdrawn
Phase 2
A Research Trial of Aralast in New Onset Diabetes (RETAIN) Start of enrollment: 2010 Oct 01
Terminated
Phase 1
ATG-GCSF in New Onset Type 1 Diabetes Start of enrollment: 2014 Dec 01
Completed
Phase 2
Tocilizumab (TCZ) in New-onset Type 1 Diabetes Start of enrollment: 2015 Mar 12
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

11 citations
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.
Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino
Diabetologia. 2024-09-01
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes.
Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino
Diabetologia. 2024-09-01
2 citations
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes.
Moshe Phillip, Peter Achenbach, Ananta Addala, Anastasia Albanese-O'Neill, Tadej Battelino
Diabetes Care. 2024-08-01

Professional Memberships

American Diabetes Association - ADA
Member
Endocrine Society - ENDO
Member
Pediatric Endocrine Society
Member